Dennis Bannister’s daughter, Demi, was the first to die.She was only 28, a beloved third-grade teacher who likely caught the virus during a training at her Columbia, S.C., school district. Doctors diagnosed her with a bladder infection, and by the time they realized their mistake, it was too late. Not long after, the family’s matriarch, Shirley, 57, complained of difficulty breathing. She was twice sent home from the emergency room before returning by ambulance and being put on a ventilator. She died soon after.Which left Dennis Bannister, childless and a widower, sitting on his porch last...…Dennis Bannister’s daughter, Demi, was the first to die.She was only 28, a beloved third-grade teacher who likely caught the virus during a training at her Columbia, S.C., school district. Doctors diagnosed her with a bladder infection, and by the time they realized their mistake, it was too late. Not long after, the family’s matriarch, Shirley, 57, complained of difficulty breathing. She was twice sent home from the emergency room before returning by ambulance and being put on a ventilator. She died soon after.Which left Dennis Bannister, childless and a widower, sitting on his porch last...WW…

This page is no longer being updated and reflects the status of vaccine progress through March 4, 2021.For more coverage about the pandemic, visit our . The first vaccine to be cleared by U.S. regulators was developed by pharmaceutical giant Pfizer and its German partner BioNTech. BioNTech began working on a vaccine in January last year, and the companies began working together in , broadening a joint effort to use the same technology to develop an influenza vaccine. In November, companies reported that the vaccine was more than 90 percent effective in late-stage trials and were granted...…This page is no longer being updated and reflects the status of vaccine progress through March 4, 2021.For more coverage about the pandemic, visit our . The first vaccine to be cleared by U.S. regulators was developed by pharmaceutical giant Pfizer and its German partner BioNTech. BioNTech began working on a vaccine in January last year, and the companies began working together in , broadening a joint effort to use the same technology to develop an influenza vaccine. In November, companies reported that the vaccine was more than 90 percent effective in late-stage trials and were granted...WW…